ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BNR vs SERA // EV/EBITDA & P/E VALUATION

Burning Rock Biotech Limited (NASDAQ) VS. Sera Prognostics Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: BNR 6 — SERA 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BNR VS. SERA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BNR SERA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 74.70% -30.00% +104.70 BNR /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -4.14% — — TIE /fcf-yield <GO>
Operating Margin -10.20% -60.00% +49.80 BNR /operating-margins <GO>
Net Profit Margin -10.30% -60.00% +49.70 BNR /net-margins <GO>
Revenue Growth (YoY) 9.20% 5.20% +4.00 BNR /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 0.20 0.00 TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 4/9 +1.00 BNR /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 19.0 49.4 -30.35 SERA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $116.5M $81.3M $35.3M BNR /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BNR REV SERA REV BNR GROSS % SERA GROSS % BNR FCF SERA FCF
FY 2025 $77.2M $81.0K 74.7% -50.0% -$4.8M -$26.3M
FY 2024 $70.7M $77.0K 70.3% -6.5% -$13.4M -$14.2M
FY 2023 $75.7M $306.0K — — -$36.0M -$27.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BNR // BETA —
SERA // BETA —